ConductScience.org, home

Library / Trials

Segmental Thoracic vs Lumbar Spinal: Recovery After Elective Cesarean

NCT07916662, Not applicable, Not yet recruiting, Adiyaman University Research Hospital

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleSegmental Thoracic vs Lumbar Spinal: Recovery After Elective CesareanClinicalTrials.gov
NCT numberNCT07916662ClinicalTrials.gov
StatusNot yet recruitingClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment100 participants, estimatedClinicalTrials.gov
Lead sponsorAdiyaman University Research HospitalClinicalTrials.gov
ConditionsCesareanClinicalTrials.gov
InterventionsLumbar spinal anesthesia, Thoracic segmental spinal anesthesiaClinicalTrials.gov
First posted2026-11-04ClinicalTrials.gov
Last updated2026-11-04ClinicalTrials.gov

Registered outcomes 7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryObstetric Quality of Recovery-11 scoreat Postoperative 24th hours
Quality of recovery was assessed using the Obstetric Quality of Recovery-11 (ObsQoR-11) questionnaire. Each item is scored from 0 to 10, yielding a total score ranging from 0 to 110, where 110 indicates the best possible recovery and 0 indicates the worst.
ClinicalTrials.gov
SecondaryMean arterial pressure0, 5, 15, 30, 45 minutes intraoperatively
Mean arterial pressure (MAP), defined as the time-weighted average arterial pressure over a single cardiac cycle, was calculated using the standard formula: MAP = \[(2 × diastolic blood pressure) + systolic blood pressure\] / 3. Continuous or intermittent MAP measurements were used to assess hemodynamic stability and adequacy of organ perfusion throughout the perioperative period. Intraoperative hypotension was predefined as a MAP \<6o mmHg.
ClinicalTrials.gov
SecondaryHeart rate0. - 5. - 15. - 30. - 45. minutes intraoperatively
Heart rate (HR), expressed as beats per minute (bpm), was continuously monitored using standard electrocardiography. HR was used as an indicator of autonomic and hemodynamic response throughout the perioperative period. Tachycardia was predefined as HR \>100 bpm and bradycardia as HR \<50 bpm.
ClinicalTrials.gov
SecondaryOnset time of sensory blockWithin 15 minutes after completion of intrathecal injectionTime from completion of intrathecal injection to loss of sensation to pinprick at the \[ T4\] dermatome, assessed every 1 minute until the level is reached.ClinicalTrials.gov
SecondaryNumber of blocked dermatomes15 minutes after completion of intrathecal injection.Highest and lowest blocked dermatome levels assessed by pinprick testing, and the total number of blocked dermatomes calculated from them.ClinicalTrials.gov
SecondaryMotor block (modified Bromage scale)1, 2, 4, 6, 12 and 24 hours after surgery
Motor block will be assessed with the modified Bromage scale (0 = able to raise the extended leg; 1 = unable to raise the extended leg but able to flex the knee; 2 = unable to flex the knee but able to move the foot; 3 = unable to move the leg or foot).
ClinicalTrials.gov
SecondaryVAS scores1, 2, 4, 6, 12 and 24 hours after surgeryNumeric rating scale (0-10) pain scores at rest and on movement. 0 refer no pain and 10 refer the worst painClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)